Equity
Procter & Gamble·Balance Sheet Statement·8 metrics
Breakdown
| Metric | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Treasury stock | $133.4B | $134.8B | $137.1B | $138.1B | $138.7B | $139.8B | $142B | $142.2B |
| Retained earnings | $123.8B | $125.4B | $127.5B | $128.9B | $130B | $132.2B | $134B | $135.4B |
| Total liabilities and stockholders' equity | $122.4B | $126.5B | $122.6B | $123B | $125.2B | $127.6B | $127.3B | $128.4B |
| Additional paid-in capital | $67.7B | $68.1B | $68.3B | $68.6B | $68.8B | $68.9B | $69B | $69.4B |
| Accumulated other comprehensive income (loss) | -$11.9B | -$10.9B | -$11.6B | -$11.3B | -$12.1B | -$12.2B | -$12.1B | -$12.3B |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $4B | $4B | $4B | $4B | $4B | $4B | $4B | $4B |
| Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding | $798M | $791M | $788M | $781M | $777M | $770M | $767M | $759M |
| Reserve for ESOP Debt Retirement | $737M | $707M | $707M | $672M | $672M | $637M | $637M | $596M |